Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Nutrition ; 29(10): 1197-203, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24012086

ABSTRACT

OBJECTIVE: The goal of this study was to investigate whether vitamin A combined with iron supplementation for preschool children resulted in improved changes in children's infectious morbidity. METHOD: In this randomized placebo-controlled and blinded field intervention trial, totally 445 preschoolers, ages 3 to 6 y old, were randomly selected. All children were randomly divided into four groups: vitamin A supplement-only group (group I), iron supplement-only group (group II), vitamin A and iron supplement group (group III), and no vitamin A and ferrous sulfate as placebo-control (group IV) for 6 mo. The morbidity of diarrhea and respiratory infections, were collected during supplementation. RESULTS: There was evidence of the lowest incidence rate of respiratory-related illnesses and fewest symptoms of runny nose, cough, and fever for children in group III compared with children in groups I, II and IV (P < 0.05). Moreover, despite the undistinguished incidence rate of vomiting, nausea, and stomach pain, the rate of diarrhea-related illness was significantly lower for children in group III than for those in the other three groups. CONCLUSION: The beneficial affects on infectious morbidity over 6 mo, highlight the potential of vitamin A plus an iron supplement for preschool-aged children.


Subject(s)
Diarrhea/epidemiology , Dietary Supplements , Iron, Dietary/administration & dosage , Respiratory Tract Infections/epidemiology , Vitamin A/administration & dosage , Child, Preschool , China/epidemiology , Cough/prevention & control , Diarrhea/complications , Diarrhea/drug therapy , Double-Blind Method , Female , Fever/prevention & control , Follow-Up Studies , Humans , Incidence , Male , Morbidity , Respiratory Tract Infections/complications , Respiratory Tract Infections/drug therapy
2.
Yao Xue Xue Bao ; 42(11): 1206-14, 2007 Nov.
Article in Chinese | MEDLINE | ID: mdl-18300480

ABSTRACT

To prepare transdermal drug delivery system (TDDS) of felodipine and metoprolol and to study its pharmaceutical characteristics, pharmacokinetics and bioavailability in rabbits, an HPLC assay was established for the simultaneous determination of felodipine and metoprolol in the permeation receptor and patch. The permeation rate and permeation mechanism of felodipine-metoprolol-TDDS through rabbit skin in vitro was examined. The determination of drug content, the examination of content uniformity and stability of the TDDS were carried out. GC-ECD assays were established for the determination of felodipine and metoprolol in plasma separately and then employed to study the pharmacokinetics and bioavailability of felodipine and metoprolol after a single dose of oral or transdermal administration in rabbits. The results indicated that the permeation of flodipine and metoprolol from the patch through excised rabbit skin exhibited zero-order kinetic characteristics. The determination of drug content and the quality control of content uniformity of the patch accorded with Pharmacopoeia of the People's Republic of China of 2005 edition and the pharmaceutical characterization showed good stability. In contrast to oral delivery, relatively constant, sustained blood concentration with minimal fluctuation and prolonged peak time were observed over a long period after transdermal administration. The relative bioavailability of felodipine and metoprolol were 275.37% and 189.76% versus oral administration respectively. It was evident that the felodipine-metoprolol-TDDS exhibited good controlled release properties that satisfied the demands of original design that enhancing bioavailability and maintaining appropriate blood levels for a prolonged time without adverse effects associated with frequent oral administration.


Subject(s)
Drug Delivery Systems , Felodipine/pharmacokinetics , Metoprolol/pharmacokinetics , Skin Absorption , Administration, Cutaneous , Animals , Antihypertensive Agents/administration & dosage , Antihypertensive Agents/blood , Antihypertensive Agents/pharmacokinetics , Area Under Curve , Azepines/chemistry , Biological Availability , Cyclohexanols/chemistry , Delayed-Action Preparations , Drug Stability , Eucalyptol , Felodipine/administration & dosage , Felodipine/blood , Female , Male , Metoprolol/administration & dosage , Metoprolol/blood , Monoterpenes/chemistry , Propylene Glycols/chemistry , Rabbits
3.
J Inorg Biochem ; 99(5): 1064-75, 2005 May.
Article in English | MEDLINE | ID: mdl-15833329

ABSTRACT

The objectives of this study were to evaluate the pharmacodynamics and pharmacokinetics of vanadyl acetylacetonate (VAC) in rats. Pharmacodynamic study was carried out using non-diabetic and diabetic rats by subcutaneous (s.c.) and intragastric (i.g.) administrations at single dose or multiple doses. Pharmacokinetic study was performed using non-diabetic rats. Results showed that VAC resulted in a significant decrease of plasma glucose levels in diabetic rats in all dosing levels, and nearly restored hyperglycemic values to normal values after s.c. injection at a single dose of 2, 4, and 8 mg vanadium (V)/kg, or after i.g. administration at multiple doses of 3 and 6 mg V/kg once daily for seven consecutive days, respectively. The VAC could be rapidly absorbed and T(max) values ranged from 0.9 +/- 0.3 h for s.c. injection to 3.0 +/- 0.9 h for i.g. administration. The average absolute bioavailabilities for i.g. administrations at a single dose of 3, 6, and 10 mg V/kg were 34.7%, 28.1%, and 22.8%, respectively. After i.g. administration at a single dose of 10 mg V/kg, the average elimination half-lives obtained from non-diabetic rats were very long ranging from 144.7 +/- 8.7 h in plasma to 657.3 +/- 34.8 h in femur tissue. In conclusion, VAC widely distributed in various tissues and accumulated more in the femur tissue. The time to reach maximal vanadium level after s.c. injection or i.g. administration was not coincident with the time to reach maximal hypoglycemic effect. The accumulated vanadium in bone, kidney or other tissues may gradually release and exert a longer action. In present dosing levels and administration routes, VAC was effective for lowering plasma glucose levels in diabetic rats and could reverse the higher triglyceride and cholesterol levels to the normal ranges. VAC did not influence the insulin levels in plasma and not cause obvious toxic signs like diarrhea.


Subject(s)
Diabetes Mellitus, Experimental/metabolism , Hydroxybutyrates/pharmacology , Hydroxybutyrates/pharmacokinetics , Hypoglycemic Agents/pharmacology , Hypoglycemic Agents/pharmacokinetics , Pentanones/pharmacology , Pentanones/pharmacokinetics , Animals , Blood Glucose/analysis , Cholesterol/blood , Diabetes Mellitus, Experimental/blood , Insulin/blood , Rats , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...